C92.0: Acute myeloblastic leukaemia [AML]
Acute Myeloblastic Leukaemia (AML) is a rapid and severe form of cancer that starts in the bone marrow and often moves quickly into the blood. It specifically affects the myeloid line of blood cells, which are responsible for the formation of platelets, red blood cells, and some types of white blood cells. AML occurs when these myeloid cells become abnormal and start to grow and accumulate uncontrollably, outpacing the production of normal blood cells. This condition can reduce the body's capacity to fight off infections, lead to easy bruising and bleeding, and cause weakness and fatigue. The disease's onset is typically rapid and the symptoms might worsen over time. Risk factors for AML include exposure to certain chemicals, radiation, certain types of chemotherapy, and some blood disorders. However, many cases don't have a clear cause.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.